Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 395 results for "hetero drugs"

Generic Sofosbuvir Pills for Sale in India to Treat Hepatitis C
Med India

Generic Sofosbuvir Pills for Sale in India to Treat Hepatitis C

Dr. Reddy's Laboratories Ltd (DRL), the country's second largest drug maker, has tied up with Hetero Drugs to sell the generic Sofosbuvir tablets (400mg) in India. The drug will make a significant difference in the diagnosis and treatment of Hepatitis C. "The ... Med India, 1 month ago
Dr. Reddy's Lab stock ends 2% higher India Infoline, 1 month ago

9 images for hetero drugs, 1 month ago
Sify, 1 month ago, 1 month ago
New Indian Express, 1 month ago
Money Control, 1 month ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Business Standard, 1 month ago
Deccan Chronicle, 5 months ago

STADA inks pact with Hetero Drugs for oncology products

cancer treatment products. "The planned cooperation initially calls for STADA to procure selected oncology products at attractive conditions. These relate to both existing products as well as new developments," it added. An expansion of the cooperation into ...
 Business Standard1 month ago Hetero Drugs in oncology deal with German co Stada  Hindu Business Line1 month ago Stada agrees oncology deal with Indian Hetero Drugs  Reuters UK1 month ago Germany's Stada Agrees Oncology Deal With Hetero Drugs  NDTV Profit1 month ago

Eye Rs 400cr increase in top line over next few yrs: Hetero

Excerpts from Closing Bell on CNBC-TV18 Watch the full show » H Speaking to CNBC-TV18, Srinivas Reddy of Hetero Drugs said the company is unlikely to make any significant impact in the first year. But in next couple of years, as number of ...
 Moneycontrol.com1 month ago See Rs 400cr increase in top line over next few yrs: Hetero  Moneycontrol.com1 month ago

Drug Controller nod for Natco Pharma, Hetero Drugs

Comment · print · T T T+· T- TOPICS The voluntary license allows the Indian companies to sell the drug in 91 countries on payment of a 7 per cent royalty on billing price to Gilead. Hyderabad-based pharmaceutical companies Natco ...
 The Hindu1 month ago North make it four in a row  INooz1 month ago

UPDATE: First off the blocks, Natco gets India's regulatory nod for hep C copy

Adds Hetero Pharma approval, pricing on drugs Share Tools India's Natco Pharma said that it has received Indian regulatory approval to locally sell its generic version of Sovaldi, the hepatitis C treatment that costs $1,000 a day in the U.S., ...
 FiercePharma1 month ago Natco Pharma gets nod to sell hepatitis C medicine in India  India Brand Equity Foundation1 month ago
India Infoline

Dr Reddy's and Hetero sign agreement to distribute hepatitis C drug in India

Dr Reddy's Laboratories Ltd., a manufacturer of active pharmaceutical ingredients, has signed an agreement with Hetero, under which Dr Reddy's will distribute and market Sofosbuvir 400mg tablets, indicated for the treatment of chronic hepatitis C, ...
 Individual.com1 month ago Dr Reddy's up 2% on pact with Hetero for Hepatitis drug  Money Control1 month ago Dr.Reddy's advances on Hetero tie-up  India Infoline1 month ago Dr Reddy's, Hetero tie up for hepatitis-C drug  Financial Chronicle1 month ago
Times of India

Karnataka DC swings into action to ensure adequate stock of swine flu drug oseltamivir across the state

The Karnataka drugs control department has swung into action to ensure that there is no shortage of anti-viral medicine oseltamivir phospate (Tamilflu) to treat the H1N1 condition. However, the department has not received the Drugs Controller ...
 PharmaBiz2 months ago NPPA directs manufacturers to ensure consistent supply of swine flu medicines  PharmaBiz2 months ago Pharma companies blame archaic law for lack of swine flu drugs  Economic Times2 months ago NPPA asks pharma companies to keep adequate stock of swine flu drugs  Economic Times2 months ago

Hetero increases anti-H1N1 drug manufacture by 400pc

One of the leading pharmaceutical company, Hetero Healthcare Limited on Thursday announced that it has increased its manufacturing of Oseltamavir, an anti H1N1 medicine, by 400 per cent. Srinivas Reddy, Marketing Director, Hetero said, The present ...
 Afternoon Despatch & Courier1 month ago Swine flu: Hetero Healthcare increases Fluvir production by 400%  ZeeNews.com1 month ago Hetero Healthcare increases Fluvir production by 400%  Economic Times1 month ago Swine flu: Hetero Health increases Fluvir production by 400%  Economic Times1 month ago
Business Standard

Natco, Hetero get drug regulator's nod for Gilead's Hep-C drug

Natco Pharma Limited today said it has received the approval for the generic anti-hepatitis C medicine sofosbuvir tablets of 400 mg from the Drugs Controller General-India (DCGI). The company would market the product through strategic partners in ...
 Business Standard India1 month ago

India's Hetero to Launch Sofosbuvir at $11.36/Pill

In news out of Hyderabad, India today, drug maker Hetero announced that it plans to launch sofosbuvir this month under the brand name Sofovir in India. This is the first registration for Gilead and Hetero's stemming from the international licensing ...
 Pharmaceutical Executive1 month ago Hetero Wins Approval for Generic Sofosbuvir in India  Contract Pharma1 month ago Hetero Received Generic Sofosbuvir (Gilead's Sovaldi) Approval From Drug Controller General of India (DCGI)  Reliance Trust1 month ago Hetero gets approval for Sofosbuvir drug  Hindu Business Line1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hetero drugs
Get updated on latest news & your favorite topics right in your inbox!
More     Less